Identification of Metabolic Phenotypes Associated With Melanoma Metastasis (NCT06400550)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• University of Texas Southwestern Medical Center — Dallas, Texas

📞 Contact the Study Coordinator

Phone: (214) 645-8968

Email: aleuna.lee@utsouthwestern.edu

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Melanoma (Skin)

• High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Birmingham, Alabama
• Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma — Tampa, Florida
• A Study to Test the Benefit of Vitamin B5 in Patients With Melanoma — Toronto, Ontario
• Zr89 + PET Companion Trial — Philadelphia, Pennsylvania
• Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma — Orange, California
• A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors — La Jolla, California

Explore by condition: All Melanoma (Skin) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.